Menopause hormone therapy prescribing in ambulatory care visits among midlife and older U.S. women from 2018 to 2019

Menopause hormone therapy (HT) is indicated for the treatment of vasomotor symptoms of menopause, premature menopause, genitourinary syndrome of menopause, and prevention of osteoporosis [1]. After the 2002 Women's Health Initiative (WHI) study results were published, HT prescribing rates plummeted 66  % amidst fears of cardiovascular disease, venous thromboembolism, and breast cancer [2]. In 2009–2010, the prevalence of HT use was 4.7 %, decreased from 22.4 % in 1999–2000 [3]. Almost no recent studies have reported HT prescribing rates in representative patient samples in the U.S.
Source: Maturitas - Category: Primary Care Authors: Tags: Short communication Source Type: research